Thursday, January 3, 2019

Forge Therapeutics Gets $11.1M

San Diego-based Forge Therapeutics, a biotechnology startup which is developing antibiotics to treat lung infections, has received $11.M in funding commitments from CARB-X, a public-private investor funding projects that target antibiotic resistant bacteria. According to Forge Therapeutics, it will initially receive $5.7M from CARB-X, with the

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.